Buscar
Mostrando ítems 11-20 de 37
Hematopoietic stem cell transplantation: clinical use and perspectives
(SOC BIOLGIA CHILE, 2012)
Hematopoietic stem cell transplantation is the accepted therapy of choice for a variety of malignant and non-malignant diseases in children and adults. Initially developed as rescue therapy for a patient with cancer after ...
Aplasia medular
(Escuela Superior Politécnica de Chimborazo, 2019-06-10)
This degree work established as a literature review and case analysis in relation to acquired aplastic anemia. Current information with respect to epidemiology, etiopathogenesis, diagnosis and treatment of so-called entity ...
Aplasia medular após transplante hepático em pediatria
(Associação Brasileira de Hematologia e Hemoterapia e daSociedade Brasileira de Transplante de Medula Óssea, 2009)
A aplasia de medula é uma das mais raras (<1%) e sérias complicações após o transplante hepático por insuficiência hepática aguda grave viral não A, não B e não C. Esta condição clínica, que acomete simultaneamente o tecido ...
Repeat Course Of Rabbit Antithymocyte Globulin As Salvage Following Initial Therapy With Rabbit Antithymocyte Globulin In Acquired Aplastic Anemia
(FERRATA STORTI FOUNDATIONPAVIA, 2015)
Latin American Collaborative Research on Aplastic Anemia (LARAA): creating a regional registry
(American Society of HematologyEstados Unidos, 2019-12-06)
Aplastic anemia (AA) is a rare but serious disease that affects hematopoietic stem cells and is characterized by pancytopenia and a hypocellular bone marrow. It can be a hereditary or acquired condition. Acquired AA has ...
XmnI polymorphism is associated with fetal hemoglobin levels in hypoplastic syndromes
(Associação Paulista de Medicina - APM, 2006-01-01)
CONTEXT AND OBJECTIVE: Acquired fetal hemoglobin (HbF) elevation has been implicated as a prognostic factor in dyserythropoietic disorders. Our objectives were to examine acquired HbF increases in aplastic anemia (AA) and ...
Terapia primaria en aplasia de médula ósea: Trasplante alogénico de progenitores hematopoyéticos vs. terapia inmunosupresora
(Sociedad de Cirugía de Bogotá, Hospital de San José y Fundación Universitaria de Ciencias de la Salud, 2007-09-01)